| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.38B | +5.1% |
| R&D Expense | $452.0M | — |
| SG&A Expense | $573.5M | +142.3% |
| Operating Income | $1.56B | +20.7% |
| Pre-tax Income | $1.32B | -0.5% |
| Income Tax | $0 | — |
| Net Income | $770.9M | -10.2% |
| EPS (Basic) | $1.79 | -6.8% |
| EPS (Diluted) | $1.78 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $618.7M | -33.4% |
| Current Assets | $1.53B | -15.2% |
| Total Assets | $19.62B | +7.7% |
| Current Liabilities | $636.2M | -49.2% |
| Long-term Debt | $8.95B | +17.6% |
| Total Liabilities | $9.91B | +25.7% |
| Stockholders' Equity | $9.71B | -6.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.49B | -10.1% |
| Investing Cash Flow | -$1.61B | +39.7% |
| Financing Cash Flow | -$1.19B | -428.4% |
| -6.8% |